Table 4.
Vaccine interests by race/ethnicity
| Variables | Overall | White | Black or African American | Hispanic (any race) | Asian + NHPI1 | Other | P Value2 |
|---|---|---|---|---|---|---|---|
| N=24,769 | N=19,232 | N= 1,148 | N= 1,942 | N= 1,524 | N= 923 | ||
| Responded to Vaccine Trial Interest Questions | 7,196 (29·1) | 5,919 (30·8) | 191 (16·6) | 531 (27·3) | 330 (21·7) | 225 (24·4) | <0·001 |
| Vaccine Trial Interest, n (%) | <0·001 | ||||||
| Yes | 4,478 (62·2) | 3,742 (63·2) | 80 (41·9) | 309 (58·2) | 208 (63·0) | 139 (61·8) | |
| No | 1,479 (20·6) | 1,163 (19·6) | 71 (37·2) | 131 (24·7) | 63 (19·1) | 51 (22·7) | |
| I'm not sure | 1,239 (17·2) | 1,014 (17·1) | 40 (20·9) | 91 (17·1) | 59 (17·9) | 35 (15·6) | |
| By Age Groups | |||||||
| Age, years <40 | <0·001 | ||||||
| Yes | 1,875 (63·0) | 1,560 (64·4) | 20 (32·8) | 144 (57·1) | 99 (66·9) | 52 (57·1) | |
| No | 600 (20·2) | 465 (19·2) | 29 (47·5) | 61 (24·2) | 24 (16·2) | 21 (23·1) | |
| I'm not sure | 501 (16·8) | 399 (16·5) | 12 (19·7) | 47 (18·7) | 25 (16·9) | 18 (19·8) | |
| Age, years >=40 | 0·006 | ||||||
| Yes | 2,603 (61·7) | 2,182 (62·4) | 60 (46·2) | 165 (59·1) | 109 (59·9) | 87 (64·9) | |
| No | 879 (20·8) | 698 (20·0) | 42 (32·3) | 70 (25·1) | 39 (21·4) | 30 (22·4) | |
| I'm not sure | 738 (17·5) | 615 (17·6) | 28 (21·5) | 44 (15·8) | 34 (18·7) | 17 (12·7) | |
| November Vaccine Interest, n (%) | |||||||
| Responded to Vaccine Interest (November 2020) Questions | 1,783 (7·2) | 1,541 (8·0) | 30 (2·6) | 94 (4·8) | 68 (4·5) | 50 (5·4) | <0·001 |
| Full approval vaccine interest | 1,275 (71·8) | 1,125 (73·2) | 9 (30·0) | 65 (69·1) | 44 (67·7) | 32 (64·0) | <0·001 |
| Emergency Use Authorization vaccine interest | 987 (55·5) | 873 (56·8) | 6 (20·0) | 52 (55·3) | 33 (49·3) | 23 (46·0) | <0·001 |
| December Vaccine Interest, n (%) | 1,352 (5·5) | 1,154 (6·0) | 30 (2·6) | 77 (4·0) | 52 (3·4) | 39 (4·2) | |
| Responded to Vaccine Interest (December 2020) | 1,121 (83·0) | 978 (84·9) | 15 (50·0) | 58 (75·3) | 44 (84·6) | 26 (66·7) | <0·001 |
| Full approval vaccine interest | 1,034 (76·8) | 901 (78·3) | 15 (50·0) | 55 (72·4) | 41 (78·8) | 22 (56·4) | <0·001 |
| Emergency Use Authorization vaccine interest | 1,783 (7·2) | 1,541 (8·0) | 30 (2·6) | 94 (4·8) | 68 (4·5) | 50 (5·4) | <0·001 |
1
Non-Hispanic Pacific Islander.
2
Chi-squared test.